Review |
The Pharmacological Potential of Mushrooms
Institute of Pharmacy, Ernst-Moritz-Arndt-University Friedrich-Ludwig-Jahn-Strasse 17, 17487 Greifswald, Germany
This review describes pharmacologically active compounds from mushrooms. Compounds and complex substances with antimicrobial, antiviral, antitumor, antiallergic, immunomodulating, anti-inflammatory, antiatherogenic, hypoglycemic, hepatoprotective and central activities are covered, focusing on the review of recent literature. The production of mushrooms or mushroom compounds is discussed briefly.
Keywords: antiatherogenic – antimicrobial – antitumor – basidiomycetes – bioactive compounds
*For reprints and all correspondence: Ulrike Lindequist, Institute of Pharmacy, Ernst-Moritz-Arndt-University, Friedrich-Ludwig-Jahn-Strasse 17, 17487 Greifswald, Germany. Tel: +49-3834-864868; Fax: +49-3834-864885; E-mail: lindequi{at}uni-greifswald.de
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. L. Badole, N. M. Patel, P. A. Thakurdesai, and S. L. Bodhankar Interaction of Aqueous Extract of Pleurotus pulmonarius (Fr.) Quel-Champ. with Glyburide in Alloxan Induced Diabetic Mice Evid. Based Complement. Altern. Med., June 1, 2008; 5(2): 159 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Liu, Y. Fukuwatari, K. Okumura, K. Takeda, K.-i. Ishibashi, M. Furukawa, N. Ohno, K. Mori, M. Gao, and M. Motoi Immunomodulating Activity of Agaricus brasiliensis KA21 in Mice and in Human Volunteers Evid. Based Complement. Altern. Med., June 1, 2008; 5(2): 205 - 219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Matsuba, H. Matsuno, M. Sakuma, and Y. Komatsu Phellinus linteus Extract Augments the Immune Response in Mitomycin C-Induced Immunodeficient Mice Evid. Based Complement. Altern. Med., March 1, 2008; 5(1): 85 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. P. Visavadiya and A. V. R. L. Narasimhacharya Asparagus Root Regulates Cholesterol Metabolism and Improves Antioxidant Status in Hypercholesteremic Rats Evid. Based Complement. Altern. Med., August 27, 2007; (2007) nem091v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. Moghaddam, M. M. Farimani, S. Salahvarzi, and G. Amin Chemical Constituents of Dichloromethane Extract of Cultivated Satureja khuzistanica Evid. Based Complement. Altern. Med., March 1, 2007; 4(1): 95 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vojdani and J. Erde Regulatory T Cells, a Potent Immunoregulatory Target for CAM Researchers: Modulating Tumor Immunity, Autoimmunity and Alloreactive Immunity (III) Evid. Based Complement. Altern. Med., September 1, 2006; 3(3): 309 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vojdani and J. Erde Regulatory T Cells, a Potent Immunoregulatory Target for CAM Researchers: Modulating Allergic and Infectious Disease Pathology (II) Evid. Based Complement. Altern. Med., June 1, 2006; 3(2): 209 - 215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Elisabetsky and L. Costa-Campos The alkaloid alstonine: a review of its pharmacological properties. Evid. Based Complement. Altern. Med., March 1, 2006; 3(1): 39 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vojdani and J. Erde Regulatory T Cells, a Potent Immunoregulatory Target for CAM Researchers: The Ultimate Antagonist (I). Evid. Based Complement. Altern. Med., March 1, 2006; 3(1): 25 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Cooper eCAM benefits from diversity that derives from CAM Evid. Based Complement. Altern. Med., September 1, 2005; 2(3): 263 - 265. [Full Text] [PDF]
|
|
E-letters:
Read all E-letters
- Thank You Oxford
- Skylar O Saveland
- Evidence-based Complementary and Alternative Medicine, 13 Dec 2005 [Full text]